Abstract
Purpose: :
To evaluate adjuvant bromfenac in ranibizumab treatment of choroidal neovascularization secondary to Age-related Macular Degeneration for the possible modulation of the duration of treatment.
Methods: :
In a retrospective case series, 60 patients on ranibizumab therapy for choroidal neovascular membrane were treated with and without combined bromfenac twice a day, with 30 in each group. The patients were evaluated with fluorescein angiography, ocular coherence tomography, and visual acuity assessment for every 4-5 weeksperiod of six months. Patients with activity leakage as demonstrated by OCT underwent subsequent injections of ranibizumab.
Results: :
Patients treated with bromfenac received 1.6 ± 0.69 injections of ranibizumab during the study period compared to 4.5 ± 0.41 injections of ranibizumab in patients without bromfenac. Patients with ranibizumab alone received significantly more (2.83 times) injections of ranibizumab (p=0.0002). Visual acuity increased 0.93 ± 3.92 in bromfenac treated patients and 0.06 Patients treated with bromfenac received 1.6 ± 0.69 injections of ranibizumab during the study period compared to 4.5 ± 0.41 injections of ranibizumab in patients without bromfenac. Patients with ranibizumab alone received significantly more (2.83 times) injections of ranibizumab (p=0.0002). Visual acuity increased 0.93 ± 3.92 lines in bromfenac treated patients and 0.06 ± 0.49 (p=0.06) in patients without bromfenac. Optical coherence tomography and fluorescein angiography data followed similar trends. There were no adverse events associated with the extended topical administration of bromfenac. Optical coherence tomography and fluorescein angiography data followed similar trends. There were no adverse events associated with the extended topical administration of bromfenac.
Conclusions: :
Bromfenac may have a role in significantly decreasing the number of injections of ranibizumab needed to control choroidal neovascular membrane associated with Age-Related Macular Degeneration. A prospective study is indicated to further delineate the interaction.
Keywords: choroid: neovascularization • macula/fovea • degenerations/dystrophies